Trial Projects
What is a Trial Project?
Demonstration of improvement in moderate to se-vere chronic PPP after guselkumab administration Evaluation of efficacy and safety of guselkumab application in patients with moderate to severe PPP Determination of improvement of quality of life due to guselkumab administration in patients with moderate to severe PPP Demonstration of improvement in moderate to severe chronic PPP after guselkumab administration
This Trial contains a sub-study with the following related objectives Exploration of the ...
Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004451-20/DE
Start date: 17th Jul 2019
End date: 20th Jul 2021
Primäres Studienziel: Die Studie soll die Detektionsrate von Adenomen im Gastrointestinaltrakt durch Gebrauch der Chromoendoskopie mit Indigokarmin im Vergleich zu konventioneller Endoskopie bei Patienten mit Polyposis Erkrankungen untersuchen.
Sekundäre Studienziele:
Der Nachweis einer erhöhten Detektionsrate von Karzinomen im oberen und unteren Gastrointestinaltrakt durch den Gebrauch der Chromoendoskopie mit 0,4% Indigokarmin bei Patienten mit FAP oder MAP.
Der Nachweis einer erhöhten ...
Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003546-27/DE#A
Start date: 18th Jul 2016
End date: 19th Dec 2017
Das Hauptziel besteht darin, die Adenomerkennungsrate (ADR) mithilfe der automatisierten Echtzeiterkennung (CAD EYE) oder der Weißlichtendoskopie (WLE) zu untersuchen
Im Rahmen dieser Studie wird der Echtzeit-Einsatz von einem Endoskop mit zusätzlicher künstlicher Intelligenz (CADEYE) bei der Darmkrebs-Überwachung von Patienten mit Lynch-Syndrom untersucht. Das Medizinprodukt wird in dieser Studie im Rahmen seiner Zweckbestimmung verwendet. Die Koloskopie ist zum gegenwärtigen Zeitpunkt die beste ...
Public web page: https://drks.de/search/de/trial/DRKS00023157
Start date: 10th Dec 2020
End date: 30th Dec 2021
The prognosis of patients with newly diagnosed glioblastoma is dismal despite recent therapeutic improvements Using standard therapy with temozolomide (TMZ) and radiotherapy (60 Gy), the median overall survival time (mOS) is 14.6 months (Stupp et al., 2005). Since in a previous non-randomized bicentric phase II trial, primary combination chemotherapy with lomustine (CCNU) and TMZ was highly effective (mOS 23 months; UKT-03 trial; Herrlinger et al., 2006; Glas et al., 2009) the proposed trial ...
Public web page: https://clinicaltrials.gov/study/NCT01149109
Start date: 1st Oct 2010
End date: 6th Apr 2017
Postoperative ileus (POI) is a frequent complication after abdominal surgery leading to nausea, vomiting and infectious complications. Bowel dysmotility can last for days and necessitates parenteral nutrition resulting in an prolonged hospital stay and a high economic burden.
Until now there is no evidence based therapy of manifest POI because of missing valid surrogate markers demonstrating the severity and resolution of POI.
A novel tool to examine gastrointestinal function is the SmartPill®. ...
Public web page: https://clinicaltrials.gov/study/NCT02329912
Start date: 1st Dec 2014
End date: 31st Dec 2016
The Ranibizumab in Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration (RIP) Study is a prospective, multicenter, uncontrolled, interventional phase 2 clinical trial that investigates the effect of fixed monthly intravitreal injections of ranibizumab (Lucentis, Novartis Pharma, Germany) on visual acuity and retinal morphology over a study period of 12 months in 30 patients.
Public web page: https://clinicaltrials.gov/study/NCT01914159
Start date: 1st Feb 2013
End date: 31st Mar 2016
Public web page: Not specified
